130 related articles for article (PubMed ID: 34431463)
21. TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
Jing L; Feng L; Zhou Z; Shi S; Deng R; Wang Z; Zhang Y; Ren Z; Liu Y
Oncol Rep; 2020 Aug; 44(2):628-636. PubMed ID: 32627044
[TBL] [Abstract][Full Text] [Related]
22. A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma.
Yang C; Huang S; Cao F; Zheng Y
BMC Cancer; 2021 Nov; 21(1):1182. PubMed ID: 34740325
[TBL] [Abstract][Full Text] [Related]
23. Identification of intestinal flora-related key genes and therapeutic drugs in colorectal cancer.
Zhang J; Zhang H; Li F; Song Z; Li Y; Zhao T
BMC Med Genomics; 2020 Nov; 13(1):172. PubMed ID: 33198757
[TBL] [Abstract][Full Text] [Related]
24. Transcriptome Profiles of Human Visceral Adipocytes in Obesity and Colorectal Cancer Unravel the Effects of Body Mass Index and Polyunsaturated Fatty Acids on Genes and Biological Processes Related to Tumorigenesis.
Del Cornò M; Baldassarre A; Calura E; Conti L; Martini P; Romualdi C; Varì R; Scazzocchio B; D'Archivio M; Masotti A; Gessani S
Front Immunol; 2019; 10():265. PubMed ID: 30838002
[TBL] [Abstract][Full Text] [Related]
25. CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study.
Huang F; Peng Y; Ye Q; Chen J; Li Y; Liu S; Xu Y; Huang L
World J Surg Oncol; 2020 Oct; 18(1):274. PubMed ID: 33099318
[TBL] [Abstract][Full Text] [Related]
26. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H
BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701
[TBL] [Abstract][Full Text] [Related]
27. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
28. SCARA5 is a Novel Biomarker in Colorectal Cancer by Comprehensive Analysis.
Liu J; Zeng ML; Shi PC; Cao YP; Zhang JL; Xie YP
Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658413
[TBL] [Abstract][Full Text] [Related]
29. Correlation of cholesteryl ester metabolism to pathogenesis, progression and disparities in colorectal Cancer.
Liu Z; Gomez CR; Espinoza I; Le TPT; Shenoy V; Zhou X
Lipids Health Dis; 2022 Feb; 21(1):22. PubMed ID: 35172832
[TBL] [Abstract][Full Text] [Related]
30. Postnatal triglyceride accumulation is regulated by mineralocorticoid receptor activation under basal and stress conditions.
Faught E; Vijayan MM
J Physiol; 2019 Oct; 597(19):4927-4941. PubMed ID: 31246274
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer.
Crous-Bou M; Rennert G; Salazar R; Rodriguez-Moranta F; Rennert HS; Lejbkowicz F; Kopelovich L; Lipkin SM; Gruber SB; Moreno V
Mutagenesis; 2012 Mar; 27(2):169-76. PubMed ID: 22294764
[TBL] [Abstract][Full Text] [Related]
32. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
[TBL] [Abstract][Full Text] [Related]
33. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
Nenkov M; Ma Y; Gaßler N; Chen Y
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200820
[TBL] [Abstract][Full Text] [Related]
34. Dysregulated lipid metabolism in colorectal cancer.
Coleman O; Ecker M; Haller D
Curr Opin Gastroenterol; 2022 Mar; 38(2):162-167. PubMed ID: 35098938
[TBL] [Abstract][Full Text] [Related]
35. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
[TBL] [Abstract][Full Text] [Related]
36. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
Yuan J; Xie A; Cao Q; Li X; Chen J
Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
[TBL] [Abstract][Full Text] [Related]
37. Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention.
Yarla NS; Gali H; Pathuri G; Smriti S; Farooqui M; Panneerselvam J; Kumar G; Madka V; Rao CV
Semin Cancer Biol; 2019 Jun; 56():168-174. PubMed ID: 30189250
[TBL] [Abstract][Full Text] [Related]
38. The role of multiple metabolic genes in predicting the overall survival of colorectal cancer: A study based on TCGA and GEO databases.
Shi W; Li X; Su X; Wen H; Chen T; Wu H; Liu M
PLoS One; 2021; 16(8):e0251323. PubMed ID: 34398900
[TBL] [Abstract][Full Text] [Related]
39. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of differentially expressed genes related to triglyceride metabolism between intramuscular fat and abdominal fat in broilers.
Liu L; Cui HX; Zheng MQ; Zhao GP; Wen J
Br Poult Sci; 2018 Oct; 59(5):514-520. PubMed ID: 29939074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
